Pharvaris PHVS
NASDAQ PHVS
$31.71 -0.02 (-0.06%)
As of: Sep 30, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Shares Outstanding (Entity) (2019 - 2025)

Updated

Pharvaris (PHVS) reported Shares Outstanding (Entity) of 65.21 million for Q4 2025, up 19.9% from 54.38 million a year earlier.

Analysis

Pharvaris (PHVS) Shares Outstanding (Entity) (2019 - 2025) Analysis & Trends

Dating back to Q4 2019, Pharvaris' Shares Outstanding (Entity) record includes 7 quarters.

  • Shares Outstanding (Entity) has increased for seven consecutive years, with a five-year compound annual growth rate of 28.4% (FY2020 to FY2025).
  • By year, Shares Outstanding (Entity) came in at 54.38 million in FY2024 (+41.6%), 38.39 million in FY2023 (+13.5%), 33.82 million in FY2022 (+2.0%) and 33.15 million in FY2021 (+77.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 2.41 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 1.77 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 1.24 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 253.35 Mn
10 Pharvaris 2.07 Bn -289,124.33 Bn 85,072.10 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 65.21 Mn
Dec 31, 2024 54.38 Mn
Dec 31, 2023 38.39 Mn
Dec 31, 2022 33.82 Mn
Dec 31, 2021 33.15 Mn
Dec 31, 2020 18.72 Mn
Dec 31, 2019 8.25 Mn
API Access

Pharvaris Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=PHVS&period=max&api_key=YOUR_API_KEY